Literature DB >> 972268

Intravenous injection of gentamicin and tobramycin without impairment of hearing.

S M Dobbs, G E Mawer.   

Abstract

The aminoglycoside antibiotics gentamicin and tobramycin were given to six healthy volunteers by intravenous injection. A dose of 80 mg was injected within 1 min. The curves relating serum concentration to time did not differ significantly for the two drugs. The maximal serum concentrations of drug exceeded 10 mug/ml on seven of 12 occasions. Despite these high concentrations, loss of hearing was not significant at any frequency (1,000-8,000 Hz) up to one month after injection. It is suggested that the aminoglycoside antibiotics penetrate into the inner ear lymph very slowly and that the concentration at that site is relatively unaffected by transient high concentrations of antibiotic in the blood plasma.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 972268     DOI: 10.1093/infdis/134.supplement_1.s114

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Serum levels of gentamicin at peak and trough in neonates and infants.

Authors:  M Shahidullah; M Q Talukder; A K Chowdhury; S Ali; A Rashid
Journal:  Indian J Pediatr       Date:  1991 Mar-Apr       Impact factor: 1.967

2.  Intravenous Push Administration of Antibiotics: Literature and Considerations.

Authors:  Samantha Spencer; Heather Ipema; Patricia Hartke; Courtney Krueger; Ryan Rodriguez; Alan E Gross; Michael Gabay
Journal:  Hosp Pharm       Date:  2018-03-08

3.  Influence of intravenous infusion duration on the tissue drug concentration profile.

Authors:  D A Uccellini; K Raymond; D J Morgan
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

Review 4.  Adverse effects of a single dose of gentamicin in adults: a systematic review.

Authors:  Rachel S Hayward; Jan Harding; Rob Molloy; Lucy Land; Kate Longcroft-Neal; David Moore; Jonathan D C Ross
Journal:  Br J Clin Pharmacol       Date:  2017-11-03       Impact factor: 4.335

5.  Kill kinetics and regrowth patterns of Escherichia coli exposed to gentamicin concentration-time profiles simulating in vivo bolus and infusion dosing.

Authors:  E B Bastone; S C Li; L L Ioannides-Demos; W J Spicer; A J McLean
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary disease.

Authors:  M T Reymann; J A Bradac; C G Cobbs; W E Dismukes
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.